Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China · Delayed Price · Currency is CNY 7.82
-0.29 (-3.58%)
Nov 13, 2026, 3:04 PM CST
SHE:300016 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,391 | 1,205 | 983.55 | 890.72 | 765.88 | 859.91 |
Revenue Growth | 23.49% | 22.54% | 10.42% | 16.30% | -10.93% | 3.94% |
Gross Profit Gross Profit Growth | 578.67 | 542.96 | 458.97 | 405.35 | 400.41 | 531.92 |
Operating Income Operating Income Growth | 161.56 | 87.86 | 53.24 | -25 | -5.12 | 127.55 |
Net Income Net Income Growth | 162.46 | 92.73 | 13.65 | -71.76 | 11.28 | 125.51 |
Earnings Per Share EPS Growth | 0.28 | 0.18 | 0.03 | -0.15 | 0.02 | 0.26 |
EPS Growth | 285.11% | 500.00% | - | - | -92.31% | -27.78% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Overseas Overseas Growth | 199.87 | 132.16 | 114.9 | - | - |
Northeast China Region Northeast China Region Growth | 75.64 | 75.05 | 82.31 | 78.89 | 93.8 |
North China North China Growth | 190.59 | 164.92 | 184.62 | 168.11 | 201.38 |
East China East China Growth | 348.13 | 245.15 | 219.86 | 186.98 | 225.18 |
Southern China Southern China Growth | 114.57 | 129.78 | 93.36 | 57.23 | 36.47 |
Central China Central China Growth | 136.43 | 125.45 | 103.16 | 109.57 | 137.5 |
Northwestern Region Northwestern Region Growth | 27.57 | 19.26 | 17.92 | 17.9 | 24.01 |
Southwest Region Southwest Region Growth | 93.68 | 80.75 | 68.17 | 84.58 | 101.93 |
Other Other Growth | 18.79 | 11.04 | 6.42 | 62.62 | 39.65 |
Total Total Growth | 1,205 | 983.55 | 890.72 | 765.88 | 859.91 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 790.16 | 675.18 | 608.23 | 748.45 | 766.73 | 895.02 |
Total Debt Total Debt Growth | 424.01 | 506.37 | 797.32 | 790.72 | 646.71 | 575.72 |
Net Cash (Debt) Net Cash Growth | 366.15 | 168.81 | -189.09 | -42.28 | 120.03 | 319.31 |
Net Cash Growth | 79.09% | - | - | - | -62.41% | 2.79% |
Net Cash Per Share Net Cash Per Share Growth | 0.64 | 0.33 | -0.42 | -0.09 | 0.21 | 0.66 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 228.27 | 156.57 | 163.02 | 58.46 | 127.81 | 108.73 |
Capital Expenditures CapEx Growth | -141.39 | -218.87 | -101.39 | -144.61 | -102.78 | -147.76 |
Free Cash Flow Free Cash Flow Growth | 86.88 | -62.3 | 61.63 | -86.15 | 25.03 | -39.03 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 41.60% | 45.05% | 46.66% | 45.51% | 52.28% | 61.86% |
Operating Margin | 11.61% | 7.29% | 5.41% | -2.81% | -0.67% | 14.83% |
Pretax Margin | 14.58% | 9.00% | -0.08% | -11.36% | -1.93% | 14.23% |
Profit Margin | 11.68% | 7.69% | 1.39% | -8.06% | 1.47% | 14.60% |
FCF Margin | 6.25% | -5.17% | 6.27% | -9.67% | 3.27% | -4.54% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.120 | - | 0.050 | - | 0.070 | 0.070 |
Dividend Per Share Growth | 0% | - | - | - | 0% | 16.67% |
Dividend Yield | 1.53% | - | 0.81% | - | 1.07% | 0.76% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 27.64 | 48.19 | 223.42 | - | 284.26 | 36.04 |
Forward PE | - | 19.22 | 19.22 | 19.22 | 19.22 | 19.22 |
P/FCF Ratio | 52.36 | - | 49.49 | - | 128.15 | - |
PS Ratio | 3.27 | 3.71 | 3.10 | 3.93 | 4.19 | 5.26 |